CD4 and non-small cell lung carcinoma: A study of 83 late-stage non-small cell lung cancer patients, which employed an antibody-dependent FISH methodology for enumerating CTCs, found that the percentages of CD3+, CD4+ and NK-cells were lower in CTC-positive than in CTC-negative patients [19].